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Abstract
Background: Neutrophil extracellular traps (NETs), webs of DNA and citrullinated his-
tones extruded from activated neutrophils cause transfusion-related acute lung
injury. Supernatants of stored red blood cell (RBC) units might promote NETosis in
neutrophils from the units or from transfusion recipients.
Hypotheses: (1) NETs form during storage of canine RBC, (2) leukoreduction (LR)
before storage of RBC reduces NETosis, and (3) supernatant from stored, non-
leukoreduced (NLR) RBC units induces NETosis in healthy canine neutrophils model-
ing transfusion recipients.
Animals: Six healthy purpose-bred research dogs were utilized for blood donation.
Methods: Prospective controlled study. RBC units were collected from each dog,
aseptically divided into 2 equal subunits, 1 of which was leukoreduced, and stored
for 42 days. Stored units were sampled biweekly for quantification of NET markers
citrullinated histone H3 (Western blot) and cell-free DNA (cfDNA) (DNA dye bind-
ing). Unit supernatants were applied ex vivo to canine neutrophils and extracellular
DNA release representing NETosis was assessed.
Results: Markers of NETs increased during RBC storage (cfDNA P < .0001 and
citrullinated H3 P = .0002) and were higher in NLR than LR units (day 42 LR cfDNA
0.34 ± 0.82 ng/mL vs day 42 NLR 1361.07 ± 741.00 ng/mL, P < .0001; day 42 LR
citrullinated H3 0.19 ± 0.13 AU vs NLR 0.57 ± 0.34 AU, P = .007). Isolated neutro-
phils did not form NETs when exposed to stored canine RBC supernatant.
Conclusions and Clinical Importance: NETosis occurs in stored canine NLR RBC
units, and is attenuated by LR before storage. NETs might be mediators of transfu-
sion reactions.
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1 | INTRODUCTION
Transfusion of blood products can be a life-saving treatment in many
companion animal diseases. However, life-threatening transfusion reac-
tions can occur. Incidence rates of overt transfusion reactions in dogs are
up to 28%, and this is likely an underestimation.1,2 Among the most com-
mon adverse events that occur with compatible blood transfusions are
febrile nonhemolytic reactions and, at least in people, transfusion-related
acute lung injury (TRALI).3 Transfusion of stored blood can induce inflam-
mation, which is undesirable in dogs that are already in a proinflammatory
state as a result of their underlying disease processes. Prestorage
leukoreduction (LR) helps eliminate post-transfusion inflammation in
dogs.4 Indeed, LR of RBC units is standard of care in human medicine and
is mandated in much of Europe as numerous studies have documented
that the risk of acute transfusion reaction is reduced by prestorage LR of
blood units.5-7 LR is not standardly employed in veterinary blood banks.
Neutrophil extracellular traps (NETs) might be key players in medi-
ating nonleukoreduced (NLR) blood induced transfusion reactions.
NETs are webs of DNA, nucleosomes, histones, and granular proteins
extruded from activated neutrophils for antimicrobial purposes, but
they can also be proinflammatory and prothrombotic.8-11 If NETs were
transfused into dogs, they could cause thrombosis and inflammation in
the recipient. NETs have been implicated in the pathogenesis of TRALI
in murine models, NET biomarkers are elevated in human patients with
TRALI, and inhibiting NETosis results in lung protection in experimental
TRALI.12,13 NETs can form in stored human RBC units and LR of units
before storage attenuates their formation.14 NETs can form in stored
blood via several mechanisms including RBC release of neutrophil-
activating proinflammatory lipid mediators and heme, a NET
inducer.15,16 Given the postulated role of NETs in the pathogenesis of
TRALI and their potential to cause other damage in transfusion recipi-
ents, documenting the generation of NETs in stored canine RBC and
NETosis attenuation by LR would support the need for LR to become
standard in veterinary medicine.
The first objective of the present study was to determine if NETs
form during the 42 day storage period of canine RBC units and if LR
prevents this process. We analyzed stored RBC units for the presence
of cell-free DNA (cfDNA), a nonspecific NET marker, and citrullinated
histones, a specific NET marker as NETosis requires histone cit-
rullination.17 Secondly, we aimed to investigate if application of super-
natant from stored canine RBC could induce NETosis in isolated
healthy dog neutrophils, modeling recipient neutrophils. We hypothe-
sized that stored canine RBC units would develop NETs as well as the
ability to induce NETosis over 42 day storage conditions and that
these processes would be attenuated by prestorage LR.
2 | MATERIALS AND METHODS
2.1 | Animals
Six purpose bred research dogs were included if they met the criteria of
weighing 17 kg or greater and had no underlying disease as determined
by a complete physical exam and screening bloodwork (complete blood
count and serum chemistry panel). The study population consisted of
4 intact male dogs and 2 intact female dogs with body weights ranging
from 17 to 25.6 kg. This study was approved by the local Institutional
Animal Care and Use Committee and dogs were cared for as outlined in
the NIH Guide for the Care and Use of Laboratory Animals.
2.2 | Blood collection and leukoreduction
Research dogs were sedated with dexmedetomidine (2-10 μg/kg)
(Dexdomitor, Zoetis, Parsippany, New Jersey) and butorphanol
(0.05-0.2 mg/kg) (Torbugesic, Zoetis, Parsippany, New Jersey) IM. Four
hundred and fifty milliliters of whole blood were collected via sterile
atraumatic jugular venipuncture from all 6 dogs into standard triple collec-
tion systems containing citrate-phosphate-dextrose-adenine for anti-
coagulation (Teruflex Blood Bag System, Terumo Corporation, Tokyo,
Japan). The sedation was reversed with 0.02 to 0.1 mg/kg atipamazole
(Anti-sedan, Zoetis, Parsippany, New Jersey) IM. Whole blood units were
centrifuged at 2493.1 g at 4C for 32 minutes. Plasma was extracted.
Optisol preservative was added to the RBCs and mixed. Using the Optisol
bag and the RBC bag and while maintaining a closed system, the RBCs
were then separated into 2 equal half-units for storage and allowed to
cool for 4 hours at 4C. One of these half-units was randomly selected to
undergo LR using a commercial LR filter (BPF Leukocyte Reduction Filtra-
tion System, Haemonetics Manufacturing, Inc., Covina, California). This
was defined as day 0. An aliquot (4 mL) was obtained pre and post filtra-
tion for evaluation of cell counts. LR was confirmed by leukocyte count
using 2 methods: complete blood counts using an automated hematology
analyzer (ADVIA 2120i Hematology System, Siemens Medical Solutions
USA Inc, Malvern, Pennsylvania) and use of a commercial propidium
iodide-based leukocyte labeling kit (BD Leucocount, BD Biosciences, San
Jose, California), according to the manufacturer's instructions, followed by
flow cytometric analysis (BD FACSCanto flow cytometer, BD Biosciences,
San Jose, California). This assay has been previously validated in canine
RBC units.18 Leukocyte counts from NLR units were reported from the
automated hematology analyzer whereas leukocyte counts from the LR
units were reported from the flow cytometric method, as these counts
were below the limit of detection of the automated hematology ana-
lyzer.19 Successful LR was defined per human blood banking standards as
less than 5 × 106 white cells per unit.20
As previously described, EDTA blood was collected at a later time
point from each research dog for neutrophil isolation in order to test
whether RBC unit supernatant induces NETosis in isolated canine
neutrophils.21,22
2.3 | Sample preparation
LR and NLR RBC units were stored at 4C for 42 days and sampled
(15 mL) on days 0, 14, 28 and 42. Samples were collected using sterile
sampling ports (HEMO-TAP Blood Bag Spike, Utah Medical Products, Inc,
Midvale, Utah) under a sterile laminar flow hood and centrifuged at
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2500g for 20 minutes at 4C without deceleration to generate cell-free
supernatants; the supernatants were removed and these were then cen-
trifuged a second time at 10000g for 5 minutes at room temperature with
deceleration to rid samples of any cellular debris. Supernatants were
stored at −80C for a maximum of 175 days before batched analysis of
NET markers and ability of unit supernatants to induce NETosis in iso-
lated canine neutrophils. On day 42, the final day of sampling, 1 mL of
blood from each unit was cultured aerobically and anaerobically to ensure
lack of bacterial contamination of units during their sampling and storage.
2.4 | Sample analysis for free hemoglobin
Hemolysis can be generated during filtration of red cells and could be
a confounding factor in our analysis. Therefore, hemolysis of the units
at each time point was quantified by means of a Drabkin's assay
according to the manufacturer's instructions. Briefly, samples were
incubated with Drabkin's reagent (Ricca Chemical Company, Arling-
ton, Texas) for 30 minutes in the dark to convert hemoglobin to
cyanmethemoglobin. Absorbance at 540 nm was measured on a Ver-
samax microplate reader (Molecular Devices, Sunnyvale, California).
A540 was converted to concentration using a standard curve of bovine
hemoglobin (Sigma Aldrich, St. Louis, Missouri).
2.5 | Sample analysis for NET markers
Two assays were performed on sample supernatants from each LR
and NLR unit at each time point to assess for evidence of NET forma-
tion during RBC storage, quantification of cell-free DNA and Western
blot analysis for citrullinated histone H3.
2.5.1 | Quantification of cell-free DNA (cfDNA)
Using previously described methods for sensitive detection of DNA, DNA
from supernatants was first purified using a commercial DNA purification
kit (QIAamp DNA Mini and Blood Mini kit, Qiagen, Valencia, California).23
Purified DNA was then diluted, mixed with PicoGreen dye (Quant-iT
PicoGreen dye, Molecular Probes, Inc., Eugene, Oregon) to label DNA
according to manufacturer's instructions, and fluorescence was detected
with a microplate spectrofluorometer (Synergy HT, BioTek Instruments,
Winooski, Vermont). DNA concentrations in samples were calculated
based on a standard curve generated by fluorometric analysis of solutions
containing known DNA concentrations (Quant-iT PicoGreen kit, Molecu-
lar Probes, Inc., Eugene, Oregon).
2.5.2 | Western blot analysis for citrullinated
histone H3
Citrullinated histones in sample supernatants were measured by West-
ern blot as a specific indicator of NETosis as previously described.24
Briefly, sample supernatants were mixed with Laemmli buffer with DTT
and then subjected to sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis. Immunoblotting was performed with an antihistone H3, cit-
rulline R2 + R8 + R17 (Abcam, Cambridge, Massachusetts) followed by
a horseradish peroxidase conjugated secondary antibody (Pierce, Rock-
ford, Illinois). Chemiluminescence detection was performed by using
Pierce ECL-2 substrate (Thermo Fisher, Waltham, Massachusetts). Films
were developed using a standard photographic procedure and quantita-
tive analysis of detected bands was carried out by densitometer scan-
ning using GelDoc XR+ and ImageLab software (BioRad Laboratories,
Hercules, California). Citrullinated histone H3 purified from septic
canine abdominal fluid was used as a standard for densitometry.
Septic abdominal fluid was selected for this purpose since NETosis
and circulating citrullinated H3 have been well-documented in
both naturally occurring sepsis and animal models of sepsis, and
NETs and citrullinated H3 have been previously documented in
canine septic abdominal fluid.25,26 Specificity of the commercial
anticitrullinated histone H3 antibody was confirmed via nano liquid
chromatography with tandem mass spectrometry as described in
Supporting file 1.
2.6 | Assessment of RBC supernatant ability to
induce NETosis in recipient neutrophils
As a model of ability of blood product to induce NETosis in recipi-
ent neutrophils, sample supernatants from day 0 and day 42 were
applied ex vivo to isolated canine neutrophils. Neutrophils were iso-
lated from EDTA blood of 6 healthy research dogs as previously
described.21,22 Briefly, erythrocytes were removed by dextran sedi-
mentation before separation of granulocytes by a Histopaque 1077
gradient (Sigma Aldrich, St. Louis, Missouri). Remaining erythrocytes
were removed by brief osmotic lysis before neutrophils were
washed in PBS, counted and resuspended in PBS after filtration
through a 70 μm sterile filter. For a final concentration of 250 000
cells/mL per well, 5 × 104 cells/well, counted using a hemocytome-
ter, were added to a sterile, tissue culture treated 96 well plate
(Microplate, Corning, Tewksbury, Massachusetts) containing Roswell
Park Memorial Institute medium (HyClone, Logan, Utah) with 0.5%
fetal calf serum (Gibco, Gaithersburg, Maryland) to a final well vol-
ume of 200 μL.
For 6 dogs, 20 μL of supernatant collected from LR and NLR
blood at day 0 and day 42 were added to the test wells containing iso-
lated neutrophils described above (10% dilution), with each condition
set up in triplicate. For 1 dog, 5% and 25% dilutions were also pre-
pared. As a positive control, cells from each dog were also stimulated
with the known NET agonist, phorbol 12-myristate 13-acetate (PMA;
final concentration 7 μM) (Sigma Aldrich, St. Louis, Missouri) and as a
negative control, nonstimulated wells in which stimulants were rep-
laced by an equal volume of PBS were also set-up. To determine if cit-
rate from the anticoagulant in blood units could be reducing cell
viability, supernatants collected from a blood bag filled with PBS were
also added to neutrophils (10% dilution). To control for DNA or
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interfering substances in supernatants, blank wells were prepared by
adding supernatants to acellular wells.
Cells were incubated for 3 hours at 39C before addition of the
nucleic acid dye, Sytox Green (Molecular Probes, Inc., Eugene, Ore-
gon) to a final concentration of 6 μM. After 15 minutes incubation at
39C, fluorescence (ex 504 nm/em 523 nm) was measured using a
microplate reader (Synergy HT, BioTek Instruments, Winooski, Ver-
mont). Viable cells are impermeable to Sytox green, so fluorescence
reflects extracellular DNA and dead or dying cells. Values were
blanked by subtracting the fluorescence of acellular wells containing
the same stimulant, and a fold change in Sytox green fluorescence cal-
culated by dividing the average fluorescence of test wells by the aver-
age fluorescence of nonstimulated neutrophils from the same dog.
2.7 | Data analysis and sample size calculation
A sample size calculation was performed using data from the literature
comparing nucleosome, a NET marker, formation in human LR and
NLR RBC units; this showed that in order to obtain an 80% power
with a type I error rate of 5%, 6 LR and 6 NLR units were needed.14
Response variables were analyzed using repeated measures analysis
of variance. Treatment, time and their interaction were fixed effects,
whereas animal was the subject of repeated measures. DNA data
were log transformed before analyses. When significance was discov-
ered, individual comparisons between time points were made by
Tukey's t-test with adjustments for multiple comparisons [Statistical
Analysis System (SAS) 9.3, SAS Institute, Inc, Cary, North Carolina]. A P-
value of <.05 was considered significant. The ability of unit superna-
tants from all time points to induce NETosis in healthy dog neutrophils
was similarly analyzed.
Correlations between test parameters (hemoglobin, cfDNA and
citrullinated histones) were assessed by using the Spearman
correlation.
Cell counts of RBC units pre and post filtration failed D'Agostino &
Pearson omnibus normality testing; cell counts pre and post filtra-
tion were thus compared with Mann-Whitney U test and are
reported as median (range) (Prism 6.0, GraphPad Software, Inc, La
Jolla, California).
3 | RESULTS
3.1 | Efficacy of LR filter
Leukoreduction was greater than 99% effective at removing leuko-
cytes and platelets in every case. In NLR blood units, the median leu-
kocyte count was 12.23 × 103/μL (range: 9.62-17.24 × 103/μL)
whereas for LR blood units the median residual leukocyte count was
0.09 cells/μL (range: 0.0-0.23 cells/μL) (P = .002). In NLR blood units,
the median platelet count was 273 × 103/μL (range: 185-338 × 103/
μL) whereas for LR blood units the median residual platelet count was
2.5 × 103/μL (range: 1.0-4.0 × 103/μL) (P = .002). The median volume
of blood that was lost by the process of filtration was 33.5 mL (range
30-35 mL), an average volume loss of 20.3% among the LR units (data
not shown). Although hemolysis occurred in stored units over time
(hemoglobin increased over time in both groups, P < .0001), there was
no difference in hemoglobin present in supernatants in LR compared
to NLR units (P = .20) (Figure 1). Blood units all cultured negative for
bacterial contamination at the conclusion of the study.
3.2 | Release of NET markers with storage
We evaluated whether neutrophils release extracellular DNA during
accepted RBC storage times of 42 days. There was significantly more
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F IGURE 1 Packed red cell unit supernatant hemoglobin levels.
Hemoglobin in supernatants collected throughout the 42 day storage
period of nonleukoreduced (NLR, A) and leukoreduced (LR, B) canine
packed red blood cell units (n = 6). For pairwise comparisons between
timepoints within a given unit type that achieved significance, P values
are reported with associated lines indicating which time points were
compared. If no line and value are reported, the comparison did not
achieve significance. *P values are for comparisons between NLR and
LR groups at each time point. Lines represent mean values with error
bars representing SD
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14 (P < .0001), 28 (P = .0014), and 42 (P < .0001) compared to day
0 with approximately 1000-fold more cfDNA in the day 42 NLR units
than in the baseline samples. There was no significant increase in
cfDNA over time in the LR group. LR units contained only 0.34 ng/mL
(± 0.82 ng/mL) DNA after 42 days compared to
1361.07 ± 741.00 ng/mL (mean ± SD) in the NLR units at 42 days
(P < .0001). Similarly, there was significantly more citrullinated histone
H3 (Figure 3) measured in supernatants of NLR samples at days 28
(P = .002) and 42 (P = .003) compared to day 0. Although Histone H3
increased in the LR group from day 0 to day 28 (P = .002), from day
14 to 28 (P = .01), and from day 0 to day 42 (P = .02), citrullinated his-
tone H3 was approximately 3-fold higher in NLR compared to LR sam-
ples on days 28 (P = .006) and 42 (P = .007). The results of a
representative Western blot for citrullinated histone H3 are depicted
in Figure 4.
Using the Spearman correlation, cfDNA and citrullinated histone
H3 results were significantly correlated (r = 0.58; P < .0001),
suggesting that both assays measure NETs. There was a weak but sig-
nificant correlation between hemoglobin and cfDNA (r = 0.32; P = .02)
and strong correlation between hemoglobin and citrullinated histone
H3 (r = 0.73; P < .0001).
3.3 | Ability of unit supernatants to induce
NETosis
Capacity of RBC unit supernatant to induce NETosis was assessed by
applying supernatant to isolated canine neutrophils and quantifying
F IGURE 3 Packed red cell unit supernatant citrullinated histone
H3. Citrullinated histone H3 measured in supernatants collected
throughout the 42 day storage period of nonleukoreduced (NLR, A)
and leukoreduced (LR, B) canine packed red blood cell units (n = 6).
For pairwise comparisons between timepoints within a given unit
type that achieved significance, P values are reported with associated
lines indicating which time points were compared. If no line and value
are reported, the comparison did not achieve significance. *P values
are for comparisons between NLR and LR groups at each time point.
Units are arbitrary absorption units. Lines represent mean values with
error bars representing SD. A given dog's LR and NLR unit samples
from all timepoints were analyzed on 1 gel/western blot. All gels/blots
were performed in parallel and the same positive control was run on
each gel against which all other samples were normalized
F IGURE 2 Packed red cell unit supernatant cell-free DNA. Cell-
free DNA (cfDNA) in supernatants collected throughout the 42 day
storage period of nonleukoreduced (NLR, A) and leukoreduced (LR, B)
canine packed red blood cell units (n = 6). For pairwise comparisons
between timepoints within a given unit type that achieved
significance, p values are reported with associated lines indicating
which time points were compared. If no line and value are reported,
the comparison did not achieve significance. *P values are for
comparisons between NLR and LR groups at each time point. Lines
represent mean values with error bars representing SD
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DNA release via Sytox Green fluorescence. One dog was excluded
from analysis because of interference from the unit supernatant
resulting in Sytox Green fluorescence in the acellular controls. There
was an effect of time on supernatant induced DNA release (P = .01),
but this effect was weak [1.9-fold increase, which is within assay vari-
ation (data not shown)] and was not prevented by LR (P = .39) (Fig-
ure 5). Confirming that neutrophils performed as expected in these
experiments, those stimulated with PMA resulted in a median fold
increase compared to unstimulated neutrophils of 21.9 (14.4-39.1).
4 | DISCUSSION
The results of this study provide evidence that markers of NETs, both
cfDNA and citrullinated histones, increase over time in stored NLR
canine RBC units. Combined, these data suggest that NETosis occurs
in stored canine RBC units, and that this process is attenuated by LR
before storage. We also found that stored RBC supernatant does not
induce NETosis in isolated neutrophils suggesting that stored blood
does not induce NETosis in the recipient's own neutrophils. Since
NETs can be prothrombotic and injurious to tissue, our documenta-
tion of NET formation in stored blood units and the ability to abrogate
the process with LR provides support for advising leukoreduction in
veterinary blood banking.
NETosis is a process by which activated neutrophils liberate DNA
decorated with granular proteins in order to trap bacteria. However,
exposed DNA and granular proteins can be damaging to tissues and
can be prothrombotic.9-12,27 NETs are also important in the pathogen-
esis of several inflammatory diseases.12,27 Transfusion of NET mate-
rial is unlikely to be beneficial to hospitalized dogs, especially given
that dogs requiring transfusions are likely to have systemic inflamma-
tion because of their underlying disease.4
NETosis requires neutrophil stimulation. Several mediators of
NETosis accumulate in stored RBC that could induce NETosis. We
documented that storage of both LR and NLR units resulted in signifi-
cant accumulation of free hemoglobin over time and heme-related
molecules are known to be strong inducers of NETs.16 Indeed, in this
study hemoglobin and cfDNA and hemoglobin and citrullinated his-
tone H3 were correlated. Though hemoglobin increased in LR units as
well as NLR units, LR would not have had sufficient remaining neutro-
phils to allow for significant NETosis. NET induction by interleukin-8
(IL-8) is another plausible mechanism of NET generation in stored
NLR blood. IL-8 increases in NLR canine pRBC units during a 35 day
storage period, but does not increase in LR units.28,29 IL-8 is a well-
established NETosis inducer.8 Additionally, activated platelets can
induce NETosis30 and NETs can activate platelets,27 thus the effect of
LR we observed could be attributed to both the filter's platelet and
leukocyte reducing effects.
TRALI is a severe form of acute respiratory distress syndrome
that is the leading cause of transfusion-related deaths in people
according to the Food and Drug Administration's surveillance data.31
Increases in circulating NET biomarkers in TRALI human patients'
blood and presence of NETs in the alveoli of mice and people with
TRALI suggest there could be a key role for NETs in TRALI pathogene-
sis.12,13 Although the incidence of TRALI in veterinary medicine is
likely much lower than it is in human medicine32 or might not occur at
F IGURE 4 Citrullinated H3 in supernatants of stored canine
packed red blood cell units. Representative Western blot analysis of
citrullinated histone H3 in 1 pair of canine nonleukoreduced (NLR)
and leukoreduced (LR) packed red blood cell units from the same dog
over the 42 day storage period. The 17.4 kDa protein ladder band is
shown. The labeled positive control is citrullinated histone H3 purified
from canine septic abdominal fluid. The entire width of the blot is
included, but the area of the gel above the 21 kDa molecular marker



















































F IGURE 5 DNA release from healthy canine neutrophils
evaluated by fluorescence. Neutrophils isolated from healthy dog
blood were incubated with and without supernatants from
nonleukoreduced (NLR, A) and leukoreduced (LR, B) stored packed
red blood cell units and Sytox green added to detect extracellular
DNA. Data is presented as fold change in fluorescence compared to
unstimulated neutrophils (mean ± SD). Supernatants from 5 NLR and
LR units were assessed for ability to induce DNA release from
isolated canine neutrophils. Assays were performed in triplicate
MCQUINN ET AL. 1899
all,1 the proinflammatory nature of NETs makes them likely players in
other transfusion reactions as well.9-11 Transfusion of NLR RBC to
healthy dogs induces significant inflammation which is eliminated by
LR of the RBC units before storage.4 In human blood banking, it is well
established that LR reduces the incidence of both transfusion reac-
tions, especially febrile nonhemolytic reactions, and inflammatory
responses33-36 and this has led LR to become standard practice in
much of Europe and Canada.37 Based on our study results, reduction
of NETosis in stored blood units could contribute to the beneficial
effects of LR. This warrants further study of NET markers in dogs
before and after transfusion with LR and NLR blood.
Our results are especially intriguing in light of recent transfusion
and NETosis data in canine immune-mediated hemolytic anemia
(IMHA). Markers of NETs are increased in dogs with IMHA and cfDNA
might predict outcome in dogs with IMHA.24,38 Given that NETs are
prothrombotic,39,40 and that thrombosis is the leading cause of mor-
bidity and mortality in IMHA,41,42 NETosis could contribute to the
development of IMHA thrombosis. Transfusion of aged pRBCs
increased death risk in dogs with hemolysis, most of which were dogs
with IMHA.43 In light of our current study's documentation that NET
material accumulates in aged NLR blood, we can speculate that
NETosis might have occurred in the aged stored units, leading to
infusion of NET material into recipients, contributing to their
prothrombotic state and increased mortality.
We were unable to clearly document that stored blood superna-
tants can induce NETosis in canine neutrophils. Although we identi-
fied a statistically significant increase in the fold change of Sytox
Green fluorescence after neutrophil incubation with day 42 superna-
tants (suggesting DNA release), the effect was weak and, in our expe-
rience, within the variation of this assay. Thus while NETosis appears
to occur in NLR stored blood units, supernatants of stored blood, at
least in our ex vivo system, did not definitively induce NETosis in
freshly isolated neutrophils but might have with longer
incubation time.
Though not a study objective, we learned during the study that
the LR filters employed (BPF Leukocyte Reduction Filtration System,
Haemonetics Manufacturing, Inc., Covina, CA), though efficacious in
removing white blood cells from canine packed RBC units, caused
marked hemolysis if RBCs were not allowed to cool before filtration.
While the optimal postcollection cool time was not investigated here,
we found 4 hours at 4C to be an adequate time to reduce hemolysis
in our supernatant samples. This observation is interesting because
the manufacturer of the LR filter states that human blood can be fil-
tered without hemolysis immediately after donation. We speculate
that cooling increased blood viscosity, slowing filtration and decreas-
ing shear force on the canine RBCs.44 There might be fundamental
differences in the blood cells of canines that make them more suscep-
tible to lysis after blood donation and immediate leukoreduction.
When using a different LR filter with canine blood, cooling the blood
for several hours before leukoreduction improved filtration efficacy.45
However, most studies utilizing newer leukoreduction filters do not
allow the blood to cool before filtration. Whether or not prefiltration
cooling enhances leukoreduction efficacy or reduces prestorage
hemolysis of red cells was not investigated in this study but further
investigation is warranted to ensure the best adaptation possible of
these human products to canine blood.
We recognize that our study has limitations. The cfDNA assay is
quantitative and demonstrated both significant accumulation of
cfDNA with RBC storage and attenuation of this process by
LR. However, cfDNA can accumulate with any form of cell death
including necrosis and apoptosis,46,47 and is not specific for NETosis.
We employed the citrullinated histone H3 assay to provide mechanis-
tic information regarding the source of the cfDNA. The citrullinated
H3 western blots were limited in that we did not have a gel loading
control since we could not be certain another protein like albumin or
immunoglobulin would be stable in the pRBC units over the 42 day
4C storage time. For this reason, although citrullinated histone H3 is
specific for NETosis, the data obtained from this assay is only semi-
quantitative. However, the correlation between our cfDNA levels and
our citrullinated histone H3 data suggests that the cfDNA source is
NETs. Furthermore, cfDNA, regardless of its origin, has inflammatory
and prothrombotic potential and thus transfusing blood containing
cfDNA from any source could be detrimental.48 Nevertheless, a spe-
cific and quantitative NET assay such as one that detects granular
protein-DNA complexes would be desirable. Though such an assay
exists in human medicine, no such assay exists for dogs and in our
experience the human assays do not work with canine samples
(data not shown).13
A second study limitation was a possible sample labeling error
between 2 samples. We suspect, based on individual dog data, that
1 dog's day 28 LR sample was mislabeled as another dog's day
28 NLR sample. The tube labeled LR showed an unexpected increase
in cfDNA on day 28 (446.1 ng/mL) that was not seen in the day
14 (0 ng/mL) or the day 42 (0 ng/mL) time point from this dog. This
likely increased the variance in our data. Despite this suspected error,
there were still significantly more cfDNA and citrullinated histone H3
in NLR compared to LR units at that time point and across all time
points.
In our assessment of the ability of RBC unit supernatants to
induce NETosis in healthy canine neutrophils, we did not assess neu-
trophil viability before incubation with supernatant. However, our
method of isolating neutrophils consistently yields 96% to 98% viable
cells. Although not assessing isolated neutrophil viability is a short-
coming of this study that we acknowledge, given that our positive
(PMA stimulated) and negative (unstimulated) cells performed as
expected, we do not believe any neutrophil viability issues impacted
results.
In summary, we demonstrated that cfDNA and citrullinated his-
tone H3, markers of NETs, significantly increase over the standard
storage life of NLR packed red blood cell units; leukoreduction signifi-
cantly reduced this effect. This provides further evidence of the
inflammatory and prothrombotic potential of stored red cells and the
potential beneficial effects of leukoreduction. To our knowledge, no
studies investigating the benefit of leukoreduced blood products to
clinical veterinary patients have been published. Nevertheless, we
believe that this work suggests that LR of blood products has
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potential to reduce transfusion-induced inflammation, particularly in
products stored 14 days or longer and when transfusing dogs that
already have a proinflammatory and prothrombotic disease like IMHA.
If LR can reduce infusion of NETs into recipients and thereby reduce
recipient inflammation and thrombotic risk, it could improve overall
transfusion safety in veterinary medicine.
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